Pacira | PCRX - Net Income


Pacira reported $4.65M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Astellas Pharma JPY 141.83B 98.31B Jun/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Cara Therapeutics USD -6.8M 1.28M Mar/2026
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
J&J USD 5.53B 299M Jun/2026
Ligand Pharmaceuticals USD 48.51M 61.85M Jun/2026
Nektar Therapeutics USD -44.9M 8.82M Mar/2026
Novo Nordisk DKK 20.99B 5.9B Jun/2026
Omeros USD -32.23M 23.81M Sep/2024
Pacira USD 4.65M 1.74M Jun/2026
Perrigo USD 74.5M 473.1M Jun/2026
Pfizer USD -248M 2.94B Jun/2026
Supernus Pharmaceuticals USD -58.37M 56.08M Jun/2026
Teva Pharmaceutical Industries USD -576M 945M Jun/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zoetis USD 691M 90M Jun/2026